Adrenal insufficiency affects somewhere between 100 and 140 people per 100,000 in developed countries. Addison’s disease, the primary form of the condition, is relatively rare, but secondary adrenal insufficiency — caused by long-term steroid use suppressing the hypothalamic-pituitary-adrenal axis — affects a much larger population than most people realize.
For patients with adrenal insufficiency considering All-on-4 dental implants, the diagnosis is not a disqualifier. It is a condition that places specific demands on surgical planning. The central concern is not whether implants will integrate, but whether the body can mount an adequate cortisol response to the stress of surgery — and what happens when it can’t.
What the adrenal glands do, and what happens when they don’t work
The adrenal glands sit above each kidney and produce several hormones essential to life. Cortisol — the principal glucocorticoid — is the one that matters most in the surgical context. Under normal circumstances, the body dramatically increases cortisol output in response to physical stress, including surgery, injury, and infection. This surge in cortisol is what allows the body to maintain blood pressure, regulate blood glucose, control inflammation, and sustain cardiovascular function during a physiological challenge.
In patients with adrenal insufficiency, that surge cannot happen. Cortisol levels are already low at baseline, and the adrenal glands cannot respond to a stress signal with the output a healthy body would produce. Surgical stress without adequate cortisol replacement creates the conditions for adrenal crisis — a medical emergency characterized by a rapid drop in blood pressure, hypoglycemia, nausea, confusion, and, without prompt treatment, circulatory collapse and death.
This is not a hypothetical risk. Adrenal crisis is a well-documented complication in surgical and dental settings, and the published literature on adrenal crisis in dental patients, while noting the event’s overall rarity, confirms that it is precipitated most often in patients with primary adrenal insufficiency undergoing stressful surgical procedures. The implication is straightforward: for patients with Addison’s disease or confirmed adrenal insufficiency, any surgery that produces more than minimal physiological stress requires a perioperative glucocorticoid management plan.
Primary versus secondary adrenal insufficiency: why it matters
The distinction between primary and secondary adrenal insufficiency shapes both the risk level and the management approach.
Primary adrenal insufficiency (Addison’s disease) results from destruction of the adrenal cortex itself — most commonly through autoimmune attack, but also through infection, infiltration, or surgical removal. Because the adrenal glands are structurally compromised, they cannot produce cortisol or aldosterone, regardless of how strongly the pituitary signals them to do so. This represents the highest-risk category for adrenal crisis under surgical stress.
Secondary adrenal insufficiency occurs when the hypothalamic-pituitary-adrenal (HPA) axis is suppressed — most commonly by long-term exogenous glucocorticoid therapy (prednisone, dexamethasone, and others). The adrenal glands in these patients are structurally intact but have been suppressed into inactivity by the feedback signal that exogenous steroids send to the pituitary. This is by far the more common scenario and affects large numbers of patients on long-term corticosteroid therapy for conditions including rheumatoid arthritis, asthma, inflammatory bowel disease, lupus, and organ transplant rejection.
The adrenal crisis risk is generally higher for primary adrenal insufficiency than for secondary forms, though secondary AI patients undergoing surgery still require careful perioperative management. Whether a patient on long-term glucocorticoids has actually developed HPA axis suppression can be assessed through an ACTH stimulation test — this is worth discussing with the prescribing physician before any elective surgical procedure.
What adrenal crisis looks like, and why it matters in surgery
The early signs of adrenal crisis include sudden hypotension, tachycardia, nausea, vomiting, abdominal pain, confusion, and low blood glucose. Without rapid recognition and treatment, the patient deteriorates to circulatory shock and loss of consciousness.
The challenge in a surgical setting is that these signs can initially be subtle or attributed to other causes — a reaction to sedation, postoperative nausea, or a pain response. A dental team managing a medically complex patient must know that adrenal insufficiency is part of the patient’s history, so that any unusual changes in vital signs during or after a procedure are evaluated with that history in mind.
This is another reason full and accurate disclosure of medical history before any dental implant procedure is not optional. A patient who presents without disclosing their Addison’s disease, or who mentions steroid use casually without flagging that they have confirmed adrenal insufficiency, creates a scenario where the team cannot respond appropriately if something goes wrong.
The stress dose protocol: what it is and why All-on-4 requires it
The standard approach to surgical management in adrenal insufficiency patients is supplemental glucocorticoid coverage, commonly called a stress dose or steroid cover. The principle is straightforward: since the body cannot produce its own cortisol response to surgical stress, the shortfall is covered by administering extra hydrocortisone before and around the procedure.
The amount of supplementation needed is proportional to the physiological stress of the surgery. Minor dental procedures — fillings, simple extractions, non-surgical treatment — produce relatively low stress responses, and evidence suggests most adrenal insufficiency patients can tolerate these with only their usual daily dose. Major oral surgery, including full-arch implant placement under sedation, produces a significantly higher physiological stress response and requires formal stress dosing.
Current perioperative guidelines recommend parenteral glucocorticoids (typically intravenous or intramuscular hydrocortisone) for procedures under general or regional anesthesia, procedures requiring prolonged fasting or inability to take oral medications, and any surgery with significant physiological demand. All-on-4 placement clearly falls into this category.
The exact protocol — dose, timing, and post-operative taper — should be determined in coordination with the patient’s endocrinologist before the procedure is scheduled. This is not a decision the dental team makes alone. It requires input from the physician managing the patient’s adrenal condition and familiar with the patient’s current cortisol requirements and overall disease status.
Oral manifestations of Addison’s disease
One of the most clinically distinctive features of Addison’s disease is mucosal hyperpigmentation, which can affect the mouth before generalized skin changes become apparent. The buccal mucosa (inner cheeks) is the most commonly affected site, but pigmentation can also appear on the gums, palatal arches, lips, and tongue. In some patients, intraoral pigmentation is the first presenting sign of adrenal insufficiency, preceding the general diagnosis by up to a decade.
This is clinically relevant in two directions. For dental teams, unexplained patchy or diffuse oral mucosal pigmentation in an otherwise healthy-appearing patient should prompt a question about adrenal history. For patients with known Addison’s disease, flagging the oral pigmentation to their dental team helps establish clinical context.
Beyond pigmentation, patients with adrenal insufficiency on long-term glucocorticoid replacement therapy may develop delayed healing and increased susceptibility to oral infection — both of which are relevant to post-implant recovery and require closer post-operative monitoring.
Bone density considerations
Long-term glucocorticoid therapy, whether as primary replacement or as treatment for secondary conditions, carries bone density implications that have been covered in other articles in this series. Patients on glucocorticoids for years may have reduced bone mineral density in the jaw and elsewhere, which affects implant planning and the quality of the osseointegration environment.
In Addison’s disease specifically, over-replacement with glucocorticoids — which affects a proportion of patients on standard dosing — compounds this risk. Bone density testing before implant planning is worthwhile for any patient with a significant history of glucocorticoid use, not just for implant planning purposes but as a general health consideration.
What to bring to a consultation
For any patient with adrenal insufficiency considering All-on-4, the following should come to the consultation:
Confirmation of your diagnosis (primary or secondary) and how it is currently managed. Your daily glucocorticoid dose and any other adrenal medications (such as fludrocortisone for Addison’s patients). Contact information for your endocrinologist or managing physician. Your most recent cortisol labs or ACTH stimulation test results if available. Whether you carry an emergency hydrocortisone kit. Any history of adrenal crisis and its trigger.
Many patients with Addison’s disease carry a steroid emergency card or wear a medical alert bracelet. This information should be explicitly communicated to the dental team before any procedure.
Questions to raise at your consultation
- How will my adrenal insufficiency be managed perioperatively, and who will coordinate with my endocrinologist?
- Does the practice have a protocol for managing adrenal crisis emergencies?
- What is the surgical team’s experience with adrenal insufficiency patients?
- What does my bone imaging show, and does long-term steroid replacement affect the implant plan?
- How will post-operative cortisol management be handled, particularly if I experience nausea or vomiting that prevents oral medication?
The last question matters more than it might seem. Post-operative nausea that prevents a patient from taking their usual oral hydrocortisone creates a gap in coverage that can precipitate a crisis hours after surgery. This needs to be anticipated and addressed with a plan — parenteral hydrocortisone readily available, clear instructions on when to administer it, and who to call.
The bottom line
Adrenal insufficiency and Addison’s disease do not disqualify patients from All-on-4 dental implants. Patients with well-managed disease who are cleared by their endocrinologist and treated by a dental team that understands perioperative cortisol management can safely undergo implant surgery.
What the condition requires is genuine preparation: confirmed coordination with the managing physician, a documented stress dosing plan, full disclosure of medical history, and a team that knows how to recognize and respond to adrenal crisis if it occurs. None of that is excessive — it is what medically informed surgical care looks like.
At All-on-Four Dental Implant Centers, we work with patients managing complex endocrine and systemic conditions. To find out whether All-on-4 is the right option for you, call us at (833) 454-4579 or request a consultation online.